Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bayer HealthCare Pharmaceuticals has received a two-year contract from Amerinet, to make Magnevist injection and Ultravist injection available to members of the Amerinet network.
Subscribe to our email newsletter
The agreement is effective March 1, 2008 through 2010. It covers Magnevist in multiple presentations, including five, 10, 15 and 20mL single-dose vials, 50 and 100mL pharmacy bulk packages, and 10, 15 and 20mL pre-filled syringes of Magnevist. Ultravist will be available in four concentrations (150, 240, 300 and 370mgI) and in a variety of product presentations, including 500mL pharmacy bulk packages for the 300mgI and 370mgI concentrations.
Douglas Stefanelli, vice president and general manager, diagnostic imaging, Bayer HealthCare Pharmaceuticals, said: “We are pleased to continue our long-standing relationship with Amerinet and remain committed to providing its members with the high-quality, cost-effective products they need to serve their patient community.”